Year All20242023202220212020201920182017201620152014 ABIVAX strengthens its Senior Leadership Team by appointing Dr. Jean-Marc Steens, M.D. as the company’s Chief Medical Officer September 23, 2015 Read More ABIVAX appoints Antonino Ligresti, MD and Dominique Costantini, MD to its Board of Directors September 15, 2015 Read More ABIVAX included in the CAC Small, CAC Mid & Small and CAC All-Tradable indices September 14, 2015 Read More ABIVAX to report first-half 2015 results September 01, 2015 Read More ABIVAX commends Cuba on being the first country in the world to eliminate mother-to-child transmission of HIV July 03, 2015 Read More Great success of ABIVAX IPO on Euronext Paris, with €57.7 million raised June 23, 2015 Read More ABIVAX launches IPO on the regulated market of Euronext in Paris June 05, 2015 Read More ABIVAX plans IPO on the Euronext regulated market in Paris May 20, 2015 Read More The Chairman of ABIVAX accompanies French President François Hollande during his trip to Cuba on May 11 May 11, 2015 Read More Mechanism of action of ABIVAX’s First-in-class anti-HIV drug published today in peer-reviewed journal Retrovirology April 13, 2015 Read More
ABIVAX strengthens its Senior Leadership Team by appointing Dr. Jean-Marc Steens, M.D. as the company’s Chief Medical Officer September 23, 2015 Read More
ABIVAX appoints Antonino Ligresti, MD and Dominique Costantini, MD to its Board of Directors September 15, 2015 Read More
ABIVAX included in the CAC Small, CAC Mid & Small and CAC All-Tradable indices September 14, 2015 Read More
ABIVAX commends Cuba on being the first country in the world to eliminate mother-to-child transmission of HIV July 03, 2015 Read More
The Chairman of ABIVAX accompanies French President François Hollande during his trip to Cuba on May 11 May 11, 2015 Read More
Mechanism of action of ABIVAX’s First-in-class anti-HIV drug published today in peer-reviewed journal Retrovirology April 13, 2015 Read More